BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Nordihydroguaiaretic Acid

A potent lipoxygenase inhibitor that interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils.

300+ PubMed studies analyzed · Evidence Score: 37

Research Domains

Nordihydroguaiaretic Acid has been studied across 18 research domains including 🔬 Oncology, 🔬 Inflammation, 🔥 Metabolic, ⚡ Energy & Fatigue, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 31% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nordihydroguaiaretic Acid, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Ethoxyquin
19 shared targets
Toxaphene
18 shared targets
Nisoldipine
27 shared targets
Zearalenone
20 shared targets
Vitamin
19 shared targets
o-Phthalaldehyde
17 shared targets
trequinsin
17 shared targets
Tannins
19 shared targets
Flutamide
19 shared targets
Lynestrenol
17 shared targets
Loading evidence profile...

This evidence profile for Nordihydroguaiaretic Acid is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.